Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
News|Articles|September 23, 2026
Menopause proteomic scores associated with cognitive aging, dementia risk
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor
Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
Advertisement
Advertisement
Using blood proteomics data from multiple cohorts to identify biological changes associated with menopause, the researchers of a new study published in Nature Medicine found that “spontaneous menopause is characterized by dysregulation in inflammatory, synaptic, metabolic, and Alzheimer’s disease biologic processes, which tracked more strongly with hormones than with age.”
Related to this article
Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging beyond the menopausal transition.
Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.
Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.
Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.
Fezolinetant was linked to VMS and sleep improvements by week 4 in the real-world OPTION-VMS study, presented at the International Menopause Society World Congress.
ACOG issued its most comprehensive menopause guidance, grading treatments for VMS, sleep, and mood symptoms.
Soma Mandal, MD, is launching “Mind, Body, & the Pause: the Perimenopause and Beyond Series” on Contemporary OB/GYN, featuring specialists from across Hackensack Meridian Health.
Advertisement
Advertisement